• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Aprima Medical Software Relocates Corporate Headquarters To Richardson, Texas

Aprima Medical Software, a leading provider of innovative electronic health records, practice management and revenue cycle management solutions for medical practices, completed a move of its corporate headquarters to Richardson, Texas.

According to company officials, its “new facility will allow Aprima, which was experienced double-digit growth in recent years, to consolidate all of its North Texas operations into a single location. Initially the 55,000-square-foot space, which is located in Richardson's Telecom Corridor, will house about 250 employees.” "We are excited to relocate all of our Dallas-area employees into one location and think it will be a big boost to our overall efficiencies and create new synergies between our various departments," said Michael Nissenbaum, President/CEO of Aprima.

"We'll be able to streamline many of our operations and believe it will ultimately enhance customer satisfaction. It also provides us much-needed room to add additional staff to accommodate our growth and to extend new career opportunities for our employees,” he added.

The new headquarters will serve as the home of Aprima's administrative and corporate staff, as well as for product development, customer support, training, project management, and RCM operations. Additional Aprima employees are located remotely across the country.

"Aprima Medical Software's relocation further validates Richardson's strong commitment to supporting leadership and innovation in the healthcare and information technology sectors," said Richardson Mayor Paul Voelker. "We are very pleased to welcome Aprima to Richardson's incredibly vibrant Telecom Corridor area. We know they will benefit from synergies with other business innovators and academic partners in our community, and we wish them much success in the future."

Exclusive Research